Berna Biotech Pharma operates in close collaboration with prestigious universities like those of Oxford, Catania, Siena, Pittsburgh and Zürich and the Jenner Institute. The current R&D projects are described below. For more information please contact us.

​

• SARS-CoV-2 Vaccine

• Antitumoral Vaccine PD-1

• Reverse Genetics with Attenuated Measles Virus

• Cancer Nanoclonals

​

Vaccine seed strains
Berna Biotech Pharma is in possession of 12 vaccine seed strains used in the past by the Swiss Serum and Vaccine Institute and approved by the Swiss Authorities. It has secured the know-how to produce demonstrably safe and efficacious vaccines that the world is needing most urgently. Please click here for more information.